Prostate cancer granted 100% from September 9, 2019 to March 3, 2023; coronary artery disease granted 60% September 13, 2019 to November 14, 2021 and 30% November 14, 2021 to March 3, 2023; erectile dysfunction granted 0% effective September 13, 2019.
